You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 217667


✉ Email this page to a colleague

« Back to Dashboard


NDA 217667 describes COLESTIPOL HYDROCHLORIDE, which is a drug marketed by Impax Labs, Ani Pharms, Edenbridge Pharms, and Zydus Pharms, and is included in five NDAs. It is available from six suppliers. Additional details are available on the COLESTIPOL HYDROCHLORIDE profile page.

The generic ingredient in COLESTIPOL HYDROCHLORIDE is colestipol hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
Summary for 217667
Tradename:COLESTIPOL HYDROCHLORIDE
Applicant:Edenbridge Pharms
Ingredient:colestipol hydrochloride
Patents:0
Pharmacology for NDA: 217667
Mechanism of ActionBile-acid Binding Activity
Medical Subject Heading (MeSH) Categories for 217667
Suppliers and Packaging for NDA: 217667
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COLESTIPOL HYDROCHLORIDE colestipol hydrochloride TABLET;ORAL 217667 ANDA Edenbridge Pharmaceuticals LLC. 42799-115 42799-115-01 120 TABLET in 1 BOTTLE (42799-115-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1GM
Approval Date:Aug 16, 2024TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.